Moscow, 24 July, 2014 – OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard”) and Millhouse LLC (“Millhouse”) today announced they have completed individual acquisitions of stakes in Biocad Holding Ltd., the main shareholder in Russian biotechnological company CJSC Biocad (“Biocad”).
Biocad specializes in the development, production and promotion of original and generic drugs in the following therapeutic categories: urology, gynecology, dermatovenerology, oncology, hematology, autoimmune and infectious diseases.
Under the terms of the deal, Pharmstandard acquired 20% of Biocad Holding, while a Millhouse-affiliated entity purchaseв a further 50% stake.
Pharmstandard financed the acquisition with its own funds.
“Biotechnology in medicine is one of the most popular investment trends nowadays”, said Pharmstandard CEO Igor Krylov. “In Russia Biocad is undoubtedly a leader in biotechnology industry and now has become a respected partner for us to explore many biopharmaceutical opportunities”.
Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard’s initial public offering.
The remaining 30% of Biocad Holdings is controlled by Dmitri Morozov, CEO and founder of Biocad, who will continue to run the company together with his top-notch management team.
***
Contacts:
|
Irina Bakhturina Head of Investor Relations OJSC Pharmstandard Tel.: +7 (495) 970-0030 Ext.2824 Fax: +7 (495) 970-0032
|
John Mann, Anna Sulimina Information Policy Department Millhouse LLC Tel.: +7 (495) 961-1307 Fax: +7 (495) 961-1308 a.sulimina@millhouse.ru |
About OJSC Pharmstandard
OJSC Pharmstandard – Russia’s leading pharmaceutical Company that develops and manufactures high-quality modern pharmaceutical products which meet the requirements of the healthcare system and the expectations of patients.
The Company’s production assets consist of 8 pharmaceutical plants located in Kursk, Ufa, Tomsk, Vladimir and in Ukraine’s Kharkov and 1 medical equipment plant in Tyumen.
Pharmstandard shares and GDRs are traded on the RTS-MICEX and LSE.
About CJSC Biocad
Biocad Holdings is a leading Russian private biopharmaceutical company, specializing in the research, development and manufacture of generic, biosimilar, and innovative drugs. Biocad works to provide more affordable therapeutic proteins and small-molecule generics to patients who previously had limited access to high-value drugs in the areas of oncology, autoimmune and infectious diseases.
www.pharmstd.ru
About Millhouse LLC
Millhouse LLC is a Moscow-based asset management company overseeing investments in a variety of industries including property development, mining and metallurgy, energy, telecommunications, technology and sport.
| Back | Print out |
